These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17591533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [Abstract] [Full Text] [Related]

  • 7. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 8. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 9. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C, du Cailar G, Ribstein J, Mimran A.
    Arch Mal Coeur Vaiss; 2003 Feb; 96(7-8):772-5. PubMed ID: 12945221
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B.
    Blood Press Suppl; 1994 Feb; 2():35-40. PubMed ID: 8061844
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B, Nalbantgil S, Yilmaz H, Zoghi M, Ozerkan F, Nalbantgil I, Onder R.
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of everolimus on left ventricular hypertrophy of de novo kidney transplant recipients: a 1 year, randomized, controlled trial.
    Paoletti E, Marsano L, Bellino D, Cassottana P, Cannella G.
    Transplantation; 2012 Mar 15; 93(5):503-8. PubMed ID: 22318246
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Mar 15; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 17. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B, Fabbian F, Giles M, Johnston A, Baker LR.
    Clin Nephrol; 1999 Dec 15; 52(6):377-82. PubMed ID: 10604646
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan 15; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 19. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr 15; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 20. Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass.
    Hernández D, González A, Rufino M, Laynez I, de la Rosa A, Porrini E, Lacalzada J, Barragán A, Lorenzo V, Torres A.
    Nephrol Dial Transplant; 2007 Sep 15; 22(9):2678-85. PubMed ID: 17510095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.